Dr. Elisha Fredman

Head of Uro-Oncology, Radiotherapy for Urinary System Cancers, and Director of Research in Oncological Radiotherapy at the Davidoff Cancer Center, Beilinson Medical Center - Petah Tikva

Radiation Oncology/Radiotherapy

Prostate Cancer, Kidney Cancer, Bladder Cancer, and Joint Pain

Dr. Elisha Fredman is a specialist in Radiation Oncology / Radiotherapy with a subspecialty in prostate, kidney, and bladder cancers, as well as expertise in radiotherapy for joint pain (arthritis). He serves as the Head of Research and Innovation in Radiation Oncology at Beilinson Medical Center, Petah Tikva. Dr. Fredman is one of the leading physicians in Israel and worldwide in the use of hydrogel spacer technology, a preparatory step before prostate radiotherapy that helps reduce its side effects. He is also an expert in focused radiotherapy for kidney cancers as an alternative to invasive surgery.

• Residency in Radiation Oncology / Radiotherapy - UH Seidman Cancer Center, Cleveland Medical Center, Ohio, USA

• Residency in Internal Medicine – MetroHealth Medical Center, Cleveland, Ohio, USA

• Doctor of Medicine – Case Western Reserve University School of Medicine, Cleveland, Ohio, USA

• Dual Degree in Neuroscience and Psychology – Brandeis University, Boston, USA

• Associate Professor, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA

• Hebrew

• English

• Hydrogel Spacer

• Prostate Cancer

• Kidney Cancer

• Bladder Cancer

• Stereotactic Ablative Radiotherapy (SABR)

• Palliative Radiation Therapy

• Radiotherapy for Joint Pain (Arthritis)